GRIP Molecular Technologies Inc.
CRISPR protease-based molecular diagnostic platform for lateral flow assay readouts
- Sector
- Medtech
- Headquarters
- SAINT PAUL, MN
- Founded
- 2019
- Latest Form D
- $500K, May 2023
- Total capital
- $650K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $650K
- 3 Form D · last May 2023
- 41 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 2 pending · first 2023
- Rank in peer group#23 of 73
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$100K
- Private capital raisedForm D · SEC · 1st filing$50K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 73 peers
Line = medianMedtech · Platform
- Granted patents#23 · top 32%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bruce BattenExecutive Officer, DirectorNamed in SEC Form D filings
- Edward GillenExecutive Officer, DirectorNamed in SEC Form D filings
- Edward LudwigDirectorNamed in SEC Form D filings
- Richard MinicusExecutive OfficerNamed in SEC Form D filings
- Rich MinicusExecutive OfficerNamed in SEC Form D filings
- Stasia OgdenExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 4- GrantedMethods, Devices, and Systems for Detecting AnalytesUSPTOUS 12,208,390
- GrantedMethods, Devices, And Systems For Detecting AnalytesUSPTOUS 11,666,907
- PendingMethods And Kits For Detecting Target Nucleic Acids Using Crispr Associated ProteasesUSPTOApplication PCTUS2026010430
Show all 4 patent records
- Methods, Devices, and Systems for Detecting AnalytesJan 28, 2025 · US 12,208,390Granted
- Methods, Devices, And Systems For Detecting AnalytesJun 6, 2023 · US 11,666,907Granted
- Methods And Kits For Detecting Target Nucleic Acids Using Crispr Associated ProteasesApplication PCTUS2026010430Pending
- Methods and Kits for Detecting Target Nucleic Acids Using CRISPR Associated ProteasesApplication 63743548Pending
Related companies, and why
- Fresenius Medical Care Council Bluffs, LLCSimilar federal contract value in Medtech · null in contracts
- OxyDial IncSimilar federal contract value in Medtech · null in contracts
- VISISONICS CORPORATIONSimilar federal contract value in Medtech · null in contracts
- Berman Medical, Inc.Similar federal contract value in Medtech · null in contracts
- PHYSCADE, INC.Similar federal contract value in Medtech · null in contracts
- Reflux CoSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .